Janne B Kjersem

Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first‐line oxaliplatin‐based treatment

Janne B Kjersem, Tone Ikdahl, Tormod Kyrre Guren et al. · Molecular Oncology · 2013 · 144 citations · Full text

Medicine, Oncology, Pharmacology +17

Let-7 miRNA-binding site polymorphism in the KRAS 3′UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/− cetuximab

Janne B Kjersem, Tone Ikdahl, Tormod Kyrre Guren et al. · BMC Cancer · 2012 · 47 citations · Full text

Medicine, Genetics, Oncology +16

FCGR2A and FCGR3A polymorphisms and clinical outcome in metastatic colorectal cancer patients treated with first-line 5-fluorouracil/folinic acid and oxaliplatin +/- cetuximab

Janne B Kjersem, Eva Skovlund, Tone Ikdahl et al. · BMC Cancer · 2014 · 37 citations · Full text

Medicine, Oncology, Pharmacology +17

AGXT and ERCC2 polymorphisms are associated with clinical outcome in metastatic colorectal cancer patients treated with 5-FU/oxaliplatin

Janne B Kjersem, Maria Thomsen, Tormod Kyrre Guren et al. · The Pharmacogenomics Journal · 2015 · 26 citations

Medicine, Molecular Medicine, Oncology +12